Basel Medical (BMGL) Cash & Equivalents (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Basel Medical (BMGL) has disclosed Cash & Equivalents for 2 consecutive years, with $2.3 million as the latest value for Q2 2025.

• Quarterly Cash & Equivalents rose 62.19% to $2.3 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 million through Jun 2025, up 62.19% year-over-year, with the annual reading at $2.4 million for FY2025, 65.99% up from the prior year.
• Cash & Equivalents hit $2.3 million in Q2 2025 for Basel Medical, up from $1.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $2.3 million in Q2 2025 to a low of $1.4 million in Q2 2024.

Peer Comparison